comprehensive -WSS

comprehensive

author：fashion 2025-09-27 15:59:24 - browse：25

Humana sign -- health business coverage from STAT — Humana’s Medicare Advantage business is faring even worse than the company let on last week. Ed Reinke/AP

Humana’s Medicare Advantage business is faring even worse than the company let on last week, with “unprecedented” numbers of older adults getting medical care and busting through its tactics for holding up payment.

The country’s second largest private Medicare insurer disclosed Thursday it’s projecting roughly half the profit in 2024 that investors had expected. The news comes a week after Humana already lowered its projected 2023 profit, which still came in at north of $3 billion before taxes.

The stock market’s punishment was swift and decisive, sinking Humana’s share price by roughly 12% at midday. Outgoing CEO Bruce Broussard worked to calm nerves on the company’s investor call, reiterating his confidence in MA. Humana went all-in on the program when it announced last year it would wind down its employer business, but that comes as regulators are beefing up scrutiny of MA plans.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： How AI helped researchers track recovery from depression

focus

WSS

A public health expert passes on football's full body collisions for youths

Experts study whether long Covid risk adds up with each reinfection

CDC's new outbreak response network to include Northeastern

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Second xenotransplant done with gene

explore

comprehensive

leisure time

Trump demands the U.S. pay no more for drugs than other countries … again

Senators: Long

Wildfire smoke exposes gaps in outdoor worker protections

Readout LOUD podcast: possible new ALS drug, artificial wombs

Medical records are filled with copy

Living organ donors deserve priority status for transplants

Medical records are filled with copy

Millions may soon lose Medicaid when they don't have to

The high cost of giving birth even with insurance

Bispecific antibodies are next new thing in cancer immunotherapy

entertainment

Living organ donors deserve priority status for transplants

Changes to biosimilar regulatory framework must prioritize patients

FDA approves first new drug developed for postpartum depression

Hearing on Medicare drug price negotiation gets unusually heated

How Vertex's cystic fibrosis drug is changing patients' lives

Biotech lab space demand falls sharply

Wikipedia

focus

focus

Wikipedia